EbolaMoDRAD is a two year European project (Collaborative Research Project) started in February 2015, coordinated by Folkhälsomyndigheten (FoHM, the Public Institute of Sweden, Professor Ali Mirazimi) in Sweden. Our consortium brings together 18 complementary partners, including 3 small and medium enterprises, one technology transfer / management company and 14 research institutions, from eight European Member States (Sweden, United Kingdom, France, Belgium, Germany, Denmark, Finland, Italy) and one African State, Senegal. The project is supported by the European Commission under the Innovative Medicine Initiative Programme.
EbolaMoDRAD in numbers
- 18 Organisations : 14 Institutes, 3 SMEs, 1 private company in charge of management
- 8 European Union Member-States
- 4 300 395 M€ EC contribution
- 2 year-duration - start February 1st, 2015
Participants
|
|
|
|
Folkhälsomyndigheten Stockholm, Sweden |
Institut National de la Santé Lyon, France |
 |
 |
|
IPD Institut Pasteur de Dakar Dakar, Senegal |
Stockholms Universitet Stockholm, Sweden |
 |
 |
|
Coris BioConcept SPRL Gembloux, Belgium |
University of Copenhagen Copenhagen, Denmark |
 |
 |
|
Public Health England Leeds, United Kingdom |
Istituto Nazionale Malattie Infettive Roma, Italy |
 |
 |
|
Institut Pasteur Lyon, France |
Staten Serum Institut Copenhagen, Denmark |
 |
 |
|
Aix Marseille Université Marseille, France |
University of Stirling Stirling, United Kingdom |
 |
 |
|
Clonit SRL Milan, Italy |
University of Helsinki Helsinki, Finland |
 |
 |
|
EMERGENCY ONG ONLUS Milan, Italy |
AJ Innuscreen GmbH Berlin, Germany |
 |
 |
|
Inserm Transfert SA Paris and Lyon, France |
University of Turku Turku, Finland |
_logotype.png)
